Clinical magnetocardiography: the unshielded bet—past, present, and future [PDF]
Magnetocardiography (MCG), which is nowadays 60 years old, has not yet been fully accepted as a clinical tool. Nevertheless, a large body of research and several clinical trials have demonstrated its reliability in providing additional diagnostic ...
D. Brisinda +5 more
doaj +2 more sources
Non-Invasive Mapping of Ventricular Action Potential Reconstructed from Contactless Magnetocardiographic Recordings in Intact and Conscious Guinea Pigs [PDF]
Optical mapping, nanotechnology-based multielectrode arrays and automated patch-clamp allow transmembrane voltage mapping with high spatial resolution, as well as L-type calcium and inward rectifier currents measurements using native mammalian ...
Riccardo Fenici +3 more
doaj +2 more sources
Progress in Clinical Magnetocardiography: The Contactless Breakthrough for Noninvasive Clinical Detection of Cardiac Ischemia Now Needs Worldwide Standardization [PDF]
Magnetocardiography has received regulatory recognition as a contactless, sensitive aid for physicians to diagnose or exclude myocardial ischemia in chest pain patients, with or without coronary obstruction.
Riccardo Fenici +3 more
doaj +2 more sources
An advanced vision of magnetocardiography as an unrivalled method for a more comprehensive non-invasive clinical electrophysiological assessment [PDF]
Decades of experimental and clinical studies, along with the most recent clinical trials, have demonstrated the diagnostic potential of magnetocardiography, particularly for the non-invasive early diagnosis of myocardial ischemia.
Riccardo Fenici +3 more
doaj +2 more sources
Non-invasive mapping of ventricular action potential waveforms reconstructed from clinical unshielded magnetocardiography. Potential diagnostic application and current limitations [PDF]
Objective: To evaluate the feasibility and limitations of reconstructing ventricular action potential waveforms using non-invasive, unshielded magnetocardiographic mapping (uMCG), highlighting differences between healthy individuals and patients, even at
Riccardo Fenici +3 more
doaj +2 more sources
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study [PDF]
DISCOVER is a 3-year observational study program of 15,983 people with type 2 diabetes initiating second-line glucose-lowering therapy in 38 countries. We investigated the association between socioeconomic status and both the availability of a baseline ...
Marília B. Gomes +14 more
doaj +2 more sources
Impact of micro‐ and macrovascular complications of type 2 diabetes on quality of life: Insights from the DISCOVER prospective cohort study [PDF]
Background The key goals of management in patients with type 2 diabetes (T2D) are to prolong life and improve quality of life. Micro‐ and macrovascular complications of T2D not only increase the risk of morbidity and mortality, but cross‐sectional ...
Suzanne V. Arnold +14 more
doaj +2 more sources
Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study [PDF]
Introduction Although individualized target glycated hemoglobin (HbA1c) levels are recommended in older people with type 2 diabetes, studies report high levels of potential overtreatment. We aimed to investigate the proportion of older patients (aged ≥65
Jesús Medina +15 more
doaj +2 more sources
Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia [PDF]
Background Evidence from prospective cardiovascular (CV) outcome trials in type 2 diabetes (T2DM) patients supports the use of sodium–glucose co-transporter-2 inhibitors (SGLT2i) to reduce the risk of CV events.
Jordi Real +10 more
doaj +2 more sources
Accurate diagnosis of ischemic heart disease without exposure to radiation using non-stress unshielded magnetocardiography [PDF]
Study objectives: To evaluate the capability and accuracy of magnetocardiography (MCG) to identify patients with ischemic chest pain from those with non-ischemic pain and to verify normalcy in the MCG in healthy subjects. Design: We studied 133 patients (
Kirsten Tolstrup +5 more
doaj +2 more sources

